NVNO
insider transactionsenVVeno Medical Corp — buys & sells by directors, officers and 10% owners A shareholder owning more than 10% of the company. Must report trades, but usually a weaker signal than an officer or director. (SEC Form 4).
Net shares · 365d
-10.1K
0 buy · 10.1K sell
Net value · 365d
-$8.9K
$0 in · $8.9K out
Sentiment · 365d
Net selling
0% buying · 100% selling
Open-market trades · 365d
4
0 buy · 10.1K sell
Net buy / sell volume
Not enough data to chart yet.
Tap or hover the chart for daily net volume. Green = net buying, red = net selling.
Transactions · 365d
-
Sell·S
Director · 10b5-1
$1.4K
140 sh · $10.31
Own -6%
-
Sell·S
Director · 10b5-1
$1.6K
140 sh · $11.52
Own -5%
-
Other·J
SVP & Chief Medical Officer
$0
100.0K sh
-
Other·J
Chief Executive Officer
$0
200.0K sh
-
Other·J
Chief Technology Officer
$0
50.0K sh
-
Sell·S
Director · 10b5-1
$1.8K
4.9K sh · $0.36
Own -5%
-
Grant·A
Director
$0
135.9K sh
Own New
-
Grant·A
Director
$0
135.9K sh
Own New
-
Grant·A
Director
$0
135.9K sh
Own New
-
Grant·A
Director
$0
135.9K sh
Own New
-
Sell·S
Director · 10b5-1
$4.1K
4.9K sh · $0.83
Own -5%
| Date▾ | Insider | Type | Shares | Value |
|---|---|---|---|---|
| Jun 11, 2026 | Duhay Francis 10b5-1 | Sell S | 140 | $1.4K |
| Mar 12, 2026 | Duhay Francis 10b5-1 | Sell S | 140 | $1.6K |
| Dec 16, 2025 | Glickman Marc H. | Other J | 100.0K | $0 |
| Dec 16, 2025 | BERMAN ROBERT ANDREW KEY | Other J | 200.0K | $0 |
| Dec 16, 2025 | Alavi Hamed | Other J | 50.0K | $0 |
| Dec 11, 2025 | Duhay Francis 10b5-1 | Sell S | 4.9K | $1.8K |
| Dec 11, 2025 | Jenusaitis Matthew | Grant A | 135.9K | $0 |
| Dec 11, 2025 | Duhay Francis | Grant A | 135.9K | $0 |
| Dec 11, 2025 | Shrivastava Sanjay | Grant A | 135.9K | $0 |
| Dec 11, 2025 | Gray Robert | Grant A | 135.9K | $0 |
| Sep 15, 2025 | Duhay Francis 10b5-1 | Sell S | 4.9K | $4.1K |
Buy Sell Non-market (grant · exercise · gift)
About NVNO insider trading
This page tracks insider transactions for enVVeno Medical Corp (NVNO) reported to the U.S. Securities and Exchange Commission on Form 4. Corporate insiders — directors, executive officers and beneficial owners of more than 10% of the stock — must disclose their trades within two business days. Open-market purchases (code P) and sales (code S) made at the insider's discretion are the most-watched opportunistic signals, while awards (A), option exercises (M) and tax-withholding (F) reflect compensation rather than conviction. Trades marked 10b5-1 were made under a pre-arranged plan and are considered routine. A cluster buy — several insiders buying within a short window — is historically a stronger bullish indicator than any single trade.